Vigabatrin

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Vigabatrin EUROPEAN PHARMACOPOEIA 11.

01/2020:2305 chromatogram obtained with the charged aerosol detector


and with reference solution (c) to identify the peaks due to
impurities D and E.
Relative retention with reference to vigabatrin (retention
time = about 11 min) : impurity A = about 0.3 ;
impurity E = about 0.5 ; impurity D = about 0.6 ;
VIGABATRIN impurity B = about 2.3.
System suitability :
Vigabatrinum – resolution : minimum 1.5 between the peaks due to
impurities E and D in the chromatogram obtained with
reference solution (c) ;
– signal-to-noise ratio : minimum 15 for the peak due to
C6H11NO2 Mr 129.2 vigabatrin in the chromatogram obtained with reference
[60643-86-9] solution (c); minimum 10 for the peak due to impurity B
in the chromatogram obtained with reference solution (d) ;
DEFINITION – symmetry factor : minimum 0.6 for the peaks due to
(4RS)-4-Aminohex-5-enoic acid. impurity D and vigabatrin in the chromatogram obtained
Content : 98.5 per cent to 101.5 per cent (anhydrous substance). with reference solution (c) ; minimum 0.6 for the peaks due
to impurities A and B in the chromatogram obtained with
CHARACTERS reference solution (b).
Appearance : white or almost white powder. Calculation of percentage contents :
Solubility : freely soluble in water, slightly soluble in methanol, – for impurities A and B, use the concentration of each
practically insoluble in methylene chloride. impurity in reference solution (b);
– for impurity D, use the concentration of impurity D in
IDENTIFICATION reference solution (c) ;
Infrared absorption spectrophotometry (2.2.24). – for impurities other than A, B and D, use the concentration
Comparison : vigabatrin CRS. of vigabatrin in reference solution (c).
TESTS Limits :
– impurity D : maximum 0.2 per cent ;
Related substances. Liquid chromatography (2.2.29).
– impurities A, B (spectrophotometer at 210 nm) : for each
Test solution. Dissolve 50.0 mg of the substance to be impurity, maximum 0.15 per cent ;
examined in water R, using sonication if necessary, and dilute
to 5.0 mL with the same solvent. – unspecified impurities : for each impurity, maximum
0.05 per cent ;
Reference solution (a). Dilute 1.0 mL of the test solution to
100.0 mL with water R. – total : maximum 0.5 per cent ;
Reference solution (b). Dissolve 7.5 mg of vigabatrin – reporting threshold : 0.03 per cent.
impurity A CRS and 7.5 mg of vigabatrin impurity B CRS in Water (2.5.12) : maximum 0.5 per cent, determined on 0.300 g.
water R and dilute to 50.0 mL with the same solvent. Dilute Sulfated ash (2.4.14): maximum 0.1 per cent, determined on
2.0 mL of the solution to 20.0 mL with water R. 1.0 g.
Reference solution (c). Dissolve 5.0 mg of vigabatrin
impurity E CRS and 10.0 mg of vigabatrin impurity D CRS ASSAY
in water R and dilute to 50.0 mL with the same solvent. To Dissolve 90 mg in 50 mL of glacial acetic acid R. Titrate
2.0 mL of the solution add 1.0 mL of reference solution (a) with 0.1 M perchloric acid, determining the end-point
and dilute to 20.0 mL with water R. potentiometrically (2.2.20).
Reference solution (d). Dilute 2 mL of reference solution (b) 1 mL of 0.1 M perchloric acid is equivalent to 12.92 mg
to 10 mL with water R. of C6H11NO2.
Column :
IMPURITIES
– size : l = 0.10 m, Ø = 4.6 mm ;
Specified impurities : A, B, D.
– stationary phase : end-capped solid core phenylhexylsilyl
silica gel for chromatography R (2.7 μm) ; Other detectable impurities (the following substances would,
if present at a sufficient level, be detected by one or other of
– temperature : 45 °C. the tests in the monograph. They are limited by the general
Mobile phase : dissolve 2.1 g of perfluoroheptanoic acid R in a acceptance criterion for other/unspecified impurities. It
mixture of 195 mL of methanol R2 and 805 mL of water for is therefore not necessary to identify these impurities for
chromatography R. demonstration of compliance. See also 5.10. Control of
Flow rate : 1.0 mL/min. impurities in substances for pharmaceutical use) : E.
Post-column solution : methanol R2.
Post-column flow rate : 0.8 mL/min.
Detection : charged aerosol detector (gas source : nitrogen at
35 psi) and, for impurities A and B, spectrophotometer at A. (5RS)-5-ethenylpyrrolidin-2-one,
210 nm.
Autosampler : set at 15 °C.
Injection : 30 μL of the test solution and reference solutions (b),
(c) and (d).
Run time : 3 times the retention time of vigabatrin. B. (2E)-2-(2-aminoethyl)but-2-enoic acid,
Identification of impurities : use the chromatogram obtained
with the spectrophotometer and with reference solution (b)
to identify the peaks due to impurities A and B ; use the D. 4-aminobutanoic acid (GABA),

4364 See the information section on general monographs (cover pages)


www.webofpharma.com
EUROPEAN PHARMACOPOEIA 11.0 Vincamine

(5.0 per cent). Disregard any peak with an area less than that
of the peak in the chromatogram obtained with reference
solution (d).
E. 2-[(2RS)-2-aminobut-3-en-1-yl]propanedioic acid. Loss on drying. Not more than 15.0 per cent, determined on
3 mg by thermogravimetry (2.2.34). Heat to 200 °C at a rate of
5 °C/min, under a stream of nitrogen for chromatography R,
01/2008:0748 at a flow rate of 40 mL/min.
corrected 11.0
ASSAY
Examine by liquid chromatography (2.2.29).
Keep the solutions in iced water before use.
Test solution. Dilute 1.0 mL of solution S (see Tests) to 5.0 mL
VINBLASTINE SULFATE with water R.
Reference solution (a). Dissolve the contents of a vial of
vinblastine sulfate CRS in 5.0 mL of water R to obtain a
Vinblastini sulfas concentration of 1.0 mg/mL.
Reference solution (b). Dissolve 1.0 mg of vincristine
sulfate CRS in 1.0 mL of reference solution (a).
Reference solution (c). Dilute 1.0 mL of reference solution (a)
to 50.0 mL with water R.
Reference solution (d). Dilute 1.0 mL of reference solution (c)
to 20.0 mL with water R.
The chromatographic procedure may be carried out using :
– a stainless steel column 0.25 m long and 4.6 mm in
C46H60N4O13S Mr 909 internal diameter packed with octylsilyl silica gel for
[143-67-9] chromatography R (5 μm). Place between the injector and
the column a precolumn packed with suitable silica gel,
DEFINITION – as mobile phase at a flow rate of 1.0 mL/min a mixture of
Vinblastine sulfate contains not less than 95.0 per 38 volumes of a 1.5 per cent V/V solution of diethylamine R
cent and not more than the equivalent of 104.0 per adjusted to pH 7.5 with phosphoric acid R, 12 volumes of
cent of methyl (3aR,4R,5S,5aR,10bR,13aR)-4- acetonitrile R and 50 volumes of methanol R,
(acetyloxy)-3a-ethyl-9-[(5S,7R,9S)5-ethyl-5-hydroxy- – as detector a spectrophotometer set at 262 nm,
9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7- – a loop injector.
methanoazacycloundecino[5,4-b]indol-9-yl]-5-hydroxy-
Inject 10 μL of each solution and record the chromatograms
8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-octahydro-1H-
for 3 times the retention time of the peak due to vinblastine.
indolizino[8,1-cd]carbazole-5-carboxylate sulfate, calculated
The assay is not valid unless : in the chromatogram obtained
with reference to the dried substance.
with reference solution (b) the resolution between the peaks
CHARACTERS due to vincristine and vinblastine is not less than 4 ; the peak
in the chromatogram obtained with reference solution (d) has
A white or slightly yellowish, crystalline powder, very
a signal-to-noise ratio not less than 5. Calculate the percentage
hygroscopic, freely soluble in water, practically insoluble in
content of C46H60N4O13S from the area of the principal peak
ethanol (96 per cent).
in each of the chromatograms obtained with the test solution
IDENTIFICATION and reference solution (a) and from the declared content of
A. Examine by infrared absorption spectrophotometry vinblastine sulfate CRS.
(2.2.24), comparing with the Ph. Eur. reference spectrum STORAGE
of vinblastine sulfate.
Store in an airtight, glass container, protected from light, at a
B. Examine the chromatograms obtained in the assay. The temperature not exceeding − 20 °C. If the substance is sterile,
principal peak in the chromatogram obtained with the store in a sterile, airtight, tamper-evident glass container.
test solution is similar in position and approximate size
to the principal peak in the chromatogram obtained with
reference solution (a). 04/2021:1800
TESTS
Solution S. Dissolve 50.0 mg in carbon dioxide-free water R
and dilute to 10.0 mL with the same solvent.
Appearance of solution. Solution S is clear (2.2.1) and not VINCAMINE
more intensely coloured than reference solution Y7 (2.2.2,
Method I).
Vincaminum
pH (2.2.3). Dilute 3 mL of solution S to 10 mL with carbon
dioxide-free water R. The pH of this solution is 3.5 to 5.0.
Related substances. Examine the chromatograms obtained
in the assay. In the chromatogram obtained with the test
solution, the area of any peak apart from the principal
peak is not greater than the area of the principal peak in
the chromatogram obtained with reference solution (c)
(2.0 per cent) and the sum of the areas of any such peaks
is not greater than 2.5 times the area of the principal peak C21H26N2O3 Mr 354.5
in the chromatogram obtained with reference solution (c) [1617-90-9]

General Notices (1) apply to all monographs and other texts 4365
www.webofpharma.com

You might also like